학술논문
T04.01.7 MAINTENANCE OF CLINICAL REMISSION WITH SB5 BIOSIMILAR AFTER SWITCH FROM ADALIMUMAB ORIGINATOR: REAL-LIFE EXPERIENCE OF A TERTIARY REFERRAL CENTER
Document Type
Abstract
Author
Source
In Digestive and Liver Disease 1 October 2020 52 Supplement 2:S120-S120
Subject
Language
ISSN
1590-8658